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In Table 2, in the first column, the third row
should read ‘‘60 to \90 by CKD-epi’’ and the
fourth row should read ‘‘C90 by CKD-epi’’ and
in the fourth column the first row should read
‘‘C90 by MDRD’’.
The online version of the original article can be found
under doi:10.1007/s13300-015-0098-y.
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Table 2 The glomerular ﬁltration rates of all subjects in Study 3 were
estimated using both the 4-variable Modiﬁcation of Diet in Renal
Disease (MDRD) equation and the Chronic Kidney Disease
Epidemiology Collaboration (CKD-epi) creatinine equation
Subject eGFR classiﬁcation <60 by MDRD 60 to <90 by MDRD ‡90 by MDRD Total
\60 by CKD-epi 49 (4.7) 3 (0.3) 0 (0.0) 52 (5.0)
60 to\90 by CKD-epi 6 (0.6) 489 (47.2) 16 (1.5) 511 (49.4)
C90 by CKD-epi 0 (0.0) 29 (2.8) 443 (42.8) 472 (45.6)
Total 55 (5.3) 521 (50.3) 459 (44.3) 1035 (100.0)
A comparison of the results of subject classiﬁcation [n (%)] based on the results of each method is displayed
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